Skip to NavigationSkip to content

News

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its targets...
Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into its diabetes care section.
UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ IL-17A...
Another study has shown hydroxychloroquine is ineffective in treating the coronavirus.
As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they...
The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million investment to...
Health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be...
A partnership between Chinese and European researchers has argued that the severity of COVID-19 could be worse in colder weather brought by winter...
Novavax, one of the leading US firms which is developing a coronavirus vaccine, is set to award executives stock options that could yield pay outs of...
There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according to a cross-party...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches